Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?

Barış, Veysel Özgür; Erdem, Ayşen

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

The Anatolian Journal of Cardiology

Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity? [Anatol J Cardiol]

Anatol J Cardiol. 2022; 26(4): 342-343 | DOI: 10.5152/AnatolJCardiol.2021.1370

Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?

Veysel Özgür Barış¹, Ayşen Erdem²
¹Department of Cardiology, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
²Department of Physiology, Faculty of Medicine, Hacettepe University Ankara, Turkey

Veysel Özgür Barış, Ayşen Erdem. Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?. Anatol J Cardiol. 2022; 26(4): 342-343

Corresponding Author: Veysel Özgür Barış, Türkiye
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar